Sign up
Quantellect · Congress · Issuer Profile
NYSE: AORTArtivion Inc
HealthcareMkt Cap $1.25BCongress ownership rank #1702

Artivion Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 8 trades in Artivion Inc (NYSE: AORT) since 2022, across 4 members, worth an estimated $265.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 6 buys against 2 sells, a modestly buy-led skew, with Democratic members responsible for 100% of the trades and Republican members 0%. The most recent disclosure shown was filed September 2026, and Gilbert Cisneros has filed the most AORT transactions among those shown, with 2. One notable disclosed move was a sale by Gilbert Cisneros on October 9, 2025, down 37.5% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Artivion Inc's current Quantellect Tide Score is 45 out of 100 (Calm Tide), Bottom 36% of universe (3998); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Artivion Inc (AORT) stock overview and the complete trade table below.

Data updated

Trades
2
Politicians
1
Filings
2
Disclosed Vol
$16.00K
Buys
1
50%
Sells
1
50%

Price & congressional trade timeline

Party breakdown

Artivion congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Sep 4, 2026Jul 16, 202650 daysBuy
$1,001 - $15,000
-1.98%Self
Nov 18, 2025Oct 9, 202540 daysSell
$1,001 - $15,000
-37.50%Self
Go to

Artivion (AORT) congressional trading FAQ

Can members of Congress legally trade Artivion (AORT) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Artivion (AORT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Artivion (AORT) trades public?

Yes. Every congressional trade in Artivion (AORT) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Artivion (AORT)?

Members of Congress have disclosed 8 trades in Artivion (AORT) worth $265.00K across 4 members, according to public STOCK Act filings.

Which members of Congress have traded Artivion (AORT)?

Recent and active filers of Artivion (AORT) disclosures include Gilbert Cisneros. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Artivion (AORT) more?

Across disclosed Artivion (AORT) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).

What is the most recent congressional Artivion (AORT) trade?

The most recent disclosed Artivion (AORT) filing reported a buy by Gilbert Cisneros, filed Sep 3, 2026.

What is Artivion (AORT)'s Tide Score?

Artivion (AORT) has a Quantellect Tide Score of 45 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewArtivion (AORT) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.